IL22 and psoriasis: showed that SHP2 in both human keratinocyte cell line (HaCaT) and human primary epidermal keratinocytes could be stimulated by IL‐22 and promoted the activation of extracellular signal regulated kinase 1/2 (ERK1/2), which may affect the progression of psoriasis.40